From the Society for Immunotherapy of Cancer's (SITC) Advances in Cancer Immunotherapy™ (ACI) educational series, this course provides an overview on cancer immunotherapy for the treatment of Hematologic Malignancies and immune-related adverse event mangement. The on-demand webinars, hosted by Drs. Capitini (University of Wisconsin Carbone Cancer Center) and Li (MUSC Hollings Cancer Center), gives an update on immunotherapy for the treatment of hematologic malignanices and immune-related adverse event management. Stay up to date with the most recent clinical recommendations and research by exploring the curated Additional Resources tab.
Target Audience
The target audience includes clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians, allied health professionals, other patient care providers, students and patient advocates. The course is designed to help all members of the cancer health care team stay connected with updates in the field of cancer immunotherapy.
SITC Online Education Disclaimer
A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Course Available Beginning: February 19, 2019
- Become familiar with clinical data on the efficacy and mechanism of action of approved therapies
- Recognize patient selection criteria for approved therapies
- Understand appropriate dosing and sequencing therapies
- Identify an inflammatory reaction produced by immune system responses including mechanisms
- Differentiate adverse events compared to cytotoxic chemotherapy and targeted agents
- Recognize timing of various immune toxicities